Total Payments
$5,230
2024 Payments
$2,079
Companies
44
Transactions
274
Medicare Patients
2,960
Medicare Billing
$649,113
Payment Breakdown by Category
Food & Beverage$5,216 (99.7%)
Education$13.61 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,216 | 273 | 99.7% |
| Education | $13.61 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534.45 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $442.93 | 27 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $424.49 | 17 | $0 (2024) |
| Inspire Medical Systems, Inc. | $364.04 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $337.18 | 17 | $0 (2024) |
| SK Life Science, Inc. | $311.77 | 14 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $261.26 | 11 | $0 (2024) |
| PFIZER INC. | $219.29 | 12 | $0 (2024) |
| EMD Serono, Inc. | $205.64 | 11 | $0 (2024) |
| Biogen, Inc. | $193.31 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,079 | 100 | Inspire Medical Systems, Inc. ($364.04) |
| 2023 | $1,575 | 79 | AbbVie Inc. ($242.28) |
| 2022 | $1,070 | 68 | Novartis Pharmaceuticals Corporation ($259.81) |
| 2021 | $222.35 | 12 | JAZZ PHARMACEUTICALS INC. ($68.03) |
| 2020 | $46.08 | 2 | Biogen, Inc. ($23.93) |
| 2019 | $107.54 | 6 | Teva Pharmaceuticals USA, Inc. ($47.42) |
| 2018 | $74.60 | 4 | Teva Pharmaceuticals USA, Inc. ($41.89) |
| 2017 | $54.05 | 3 | Supernus Pharmaceuticals, Inc. ($23.54) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.30 | General |
| 12/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Neuropsychiatry | ||||||
| 11/27/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Rare Disease | ||||||
| 11/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: PAIN | ||||||
| 10/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 904 | 1,522 | $1.1M | $207,902 |
| 2022 | 10 | 836 | 1,437 | $951,175 | $191,978 |
| 2021 | 11 | 612 | 1,068 | $485,970 | $124,185 |
| 2020 | 10 | 608 | 1,038 | $518,240 | $125,047 |
Total Patients
2,960
Total Services
5,065
Medicare Billing
$649,113
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 47 | 62 | $403,000 | $50,381 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 284 | 480 | $144,000 | $43,186 | 30.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 125 | 522 | $104,400 | $33,292 | 31.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 52 | 52 | $39,000 | $18,321 | 47.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 95 | 105 | $57,750 | $14,708 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $46,800 | $12,990 | 27.8% |
| G0427 | Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth | Office | 2023 | 86 | 86 | $44,200 | $12,888 | 29.2% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 47 | 47 | $164,500 | $9,548 | 5.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2023 | 36 | 36 | $25,200 | $6,032 | 23.9% |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Office | 2023 | 24 | 24 | $8,362 | $2,532 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,395 | $2,289 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,435 | $1,735 | 31.9% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2022 | 48 | 54 | $328,500 | $43,777 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 283 | 472 | $139,230 | $42,912 | 30.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 126 | 525 | $104,160 | $30,054 | 28.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 57 | 57 | $47,710 | $20,931 | 43.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 102 | 102 | $59,280 | $17,701 | 29.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 88 | 94 | $51,515 | $15,067 | 29.2% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 50 | 50 | $175,000 | $10,109 | 5.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2022 | 45 | 45 | $31,500 | $7,586 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $10,290 | $2,953 | 28.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 14 | $3,990 | $888.39 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 203 | 369 | $105,165 | $36,220 | 34.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 106 | 383 | $74,685 | $22,658 | 30.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 93 | 98 | $53,410 | $16,153 | 30.2% |
About Dr. Preethi Durgam, D.O
Dr. Preethi Durgam, D.O is a Epilepsy healthcare provider based in Tomball, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982929253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Preethi Durgam, D.O has received a total of $5,230 in payments from pharmaceutical and medical device companies, with $2,079 received in 2024. These payments were reported across 274 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($5,216).
As a Medicare-enrolled provider, Durgam has provided services to 2,960 Medicare beneficiaries, totaling 5,065 services with total Medicare billing of $649,113. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology
- Location Tomball, TX
- Active Since 03/30/2010
- Last Updated 03/30/2022
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1982929253
Products in Payments
- KESIMPTA (Drug) $442.93
- INSPIRE (Device) $364.04
- NURTEC ODT (Drug) $354.56
- INGREZZA (Drug) $284.42
- QULIPTA (Drug) $184.83
- UBRELVY (Drug) $177.99
- DUOPA (Drug) $171.63
- Leqembi (Drug) $158.83
- Austedo XR (Drug) $145.70
- Ongentys (Drug) $140.07
- TYSABRI (Biological) $126.67
- EPIDIOLEX (Drug) $112.59
- ZEPOSIA (Drug) $111.40
- REXULTI (Drug) $108.95
- NUPLAZID (Drug) $106.67
- ULTOMIRIS (Biological) $102.57
- XYWAV (Drug) $97.80
- OCREVUS (Biological) $92.28
- AUSTEDO (Drug) $91.25
- Sunosi (Drug) $87.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.